Journal of Medical Oncology and Therapeutics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Short Communication - Journal of Medical Oncology and Therapeutics (2025) Volume 10, Issue 3

Patient-Centered Approaches in Oncology Clinical Trials: Improving Recruitment and Retention

Debra Kiess *

Department of Oncology, University of Toronto, Canada

*Corresponding Author:
Debra Kiess
Department of Oncology, University of Toronto, Canada
E-mail: debra.kiess@utoronto.ca

Received: 1-May-2025, Manuscript No. JMOT-25-164957; Editor assigned: 5-May-2025, PreQC No. JMOT-25-164957 (PQ) Reviewed:19-May-2025, QC No. JMOT-25-164957Revised:26-May-2025, Manuscript No. JMOT-25-164957; Published:31-May-2025, DOI: 10.35841/jmot- 10.3.267

Citation: Kiess D. Patient-centered approaches in oncology clinical trials: Improving recruitment and retention. J Med Oncl Ther. 2025;10(3):267

Visit for more related articles at Journal of Medical Oncology and Therapeutics

Introduction

Oncology clinical trials are a critical component of advancing cancer treatment, providing essential data that help researchers develop more effective therapies. However, the success of these trials hinges not only on the scientific rigor of the research but also on the involvement and engagement of patients. Despite the increasing number of clinical trials for cancer therapies, patient recruitment and retention remain significant challenges. Low participation rates and high dropout rates can undermine the quality and validity of clinical trials. To address these issues, a shift toward patient-centered approaches has become necessary to enhance recruitment and retention, ensuring that clinical trials are accessible, acceptable, and responsive to the needs of patients [1].

Recruitment and retention are fundamental to the success of oncology clinical trials. The recruitment process, which involves attracting eligible participants, is often hindered by several factors. These may include lack of awareness about available trials, the complexity of trial protocols, and geographic or financial barriers. In addition, many patients may feel overwhelmed by the idea of participating in a clinical trial due to fear of unknown side effects, concerns about the treatment’s effectiveness, or the time commitment required [2].

Retention is another challenge that often plagues oncology trials. Even once patients are enrolled, they may drop out due to adverse side effects, the burden of frequent hospital visits, a perceived lack of benefit, or a change in health status. These challenges can lead to incomplete data, increased trial costs, and delays in bringing new therapies to market. Therefore, it is crucial to design clinical trials that address these issues and create an environment that prioritizes the patient experience [3].

A patient-centered approach in oncology clinical trials is one that actively considers and integrates the needs, preferences, and values of patients into the design and execution of the trial. This approach goes beyond simply offering treatment options and instead involves treating patients as partners in the research process. By ensuring that patients’ perspectives are considered in trial design, recruitment strategies, and throughout the study duration, clinical trials can become more inclusive and accessible, leading to better outcomes for both patients and researchers [4].

Key elements of a patient-centered approach include providing clear and comprehensive information about the trial, ensuring logistical support, addressing concerns about side effects and treatment options, and creating a supportive and empathetic environment for patients. It also involves recognizing the personal and emotional impact of participating in a clinical trial, offering flexibility, and accommodating patient preferences when possible [5].

One of the first steps in improving recruitment is increasing awareness of clinical trials. Many patients are unaware that clinical trials are available or are not informed about the potential benefits of participation. Educational initiatives aimed at both healthcare providers and patients can play a key role in bridging this gap. Patients who understand the potential for clinical trials to provide access to cutting-edge treatments and contribute to scientific progress are more likely to consider participation [6].

Moreover, increasing accessibility to clinical trials is essential. Many patients may not participate because they live in remote areas or lack the financial means to travel to trial sites. Incorporating telemedicine into clinical trial protocols can help mitigate this barrier, allowing patients to participate in follow-up appointments or even some aspects of the trial remotely. Additionally, offering financial support, such as covering travel expenses or providing accommodations, can make trials more accessible to a broader range of patients [7].

Traditional oncology clinical trials often have rigid protocols and long, complex procedures that can overwhelm or discourage patients from participating. A more flexible trial design can make participation more feasible and less burdensome for patients. For example, trials can be designed with more convenient scheduling, fewer hospital visits, or shorter treatment durations. Personalizing the experience for each patient, such as by considering their specific medical history or treatment preferences, can also enhance the experience [8].

Furthermore, incorporating adaptive trial designs can allow for modifications during the trial based on interim data, improving patient experience by reducing the duration of ineffective treatments. These flexible approaches not only benefit patients but also allow researchers to obtain more relevant data faster and with fewer patient withdrawals [9].

Clear, ongoing communication is key to improving patient satisfaction and retention in clinical trials. Providing patients with easily understandable information about the trial, its goals, and potential risks and benefits is essential. Medical jargon should be avoided, and trial materials should be available in multiple formats to cater to different literacy levels and languages. Engaging patients in conversations about their concerns, expectations, and any potential anxieties they may have can also improve their comfort and confidence in the trial process [10].

Conclusion

Patient-centered approaches in oncology clinical trials represent a crucial shift in the way cancer research is conducted. By focusing on improving recruitment and retention through better communication, flexibility, support, and the use of technology, clinical trials can become more accessible, inclusive, and effective. In turn, these improvements will not only enhance the patient experience but also contribute to the development of better cancer treatments, ultimately benefiting future generations of cancer patients.

References

  1. Chhatre S, Jefferson A, Cook R, et al. Patient-centered recruitment and retention for a randomized controlled study. Trials. 2018;19:1-0.

    2. Indexed at, Google Scholar, Cross Ref

  2. Wilkins CH, Edwards TL, Stroud M, et al. The recruitment innovation center: Developing novel, person-centered strategies for clinical trial recruitment and retention. J Clin Transl Sci. 2021;5(1):e194.

    3. Indexed at, Google Scholar, Cross Ref

  3. Hurd TC, Kaplan CD, Cook ED, et al. Building trust and diversity in patient-centered oncology clinical trials: An integrated model. Clinical Trials. 2017;14(2):170-9.

    4. Indexed at, Google Scholar, Cross Ref

  4. Tong A, Scholes-Robertson N, Hawley C, et al. Patient-centred clinical trial design. Nat Rev Nephrol. 2022;18(8):514-23.

    5. Indexed at, Google Scholar, Cross Ref

  5. Stergiopoulos S, Michaels DL, Kunz BL, et al. Measuring the impact of patient engagement and patient centricity in clinical research and development. Ther Innov Regul Sci. 2020;54:103-16.

    6. Indexed at, Google Scholar, Cross Ref

  6. Bader M, Zheng L, Rao D, et al. Towards a more patient-centered clinical trial process: A systematic review of interventions incorporating health literacy best practices. Contemp Clin Trials. 2022;116:106733.

    7. Indexed at, Google Scholar, Cross Ref

  7. Farah E, Kenney M, Kica A, et al. Beyond participation: Evaluating the role of patients in designing oncology clinical trials. Curr Oncol. 2023;30(9):8310-27.

    8. Indexed at, Google Scholar, Cross Ref

  8. Werts SJ, Lavelle SA, Crane TE, et al. Recruitment and retention strategies used in dietary randomized controlled interventions with cancer survivors: A systematic review. Cancers. 2023;15(17):4366.

    9. Indexed at, Google Scholar, Cross Ref

  9. Trivedi RB, Szarka JG, Beaver K, et al. Recruitment and retention rates in behavioral trials involving patients and a support person: A systematic review. Contemp Clin Trials. 2013;36(1):307-18.

    10. Indexed at, Google Scholar, Cross Ref

  10. Islam KM, Opoku ST, Apenteng BA, et al. Engaging patients and caregivers in patient-centered outcomes research on advanced stage lung cancer: Insights from patients, caregivers, and providers. J Cancer Educ. 2014;29:796-801.

    11. Indexed at, Google Scholar, Cross Ref

Get the App